Most sold healthcare stocks in Q1 2023
See which Healthcare stocks institutional investors trimmed or exited the most in Q1 2023, measured as net reductions in reported share positions from Q4 2022 into Q1 2023. Notable reductions at the top of this list include BOSTON SCIENTIFIC CORP (BSX), TEVA PHARMACEUTICAL-SP ADR (TEVA), FATE THERAPEUTICS INC (FATE), NUVATION BIO INC (NUVB). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| BSX | BOSTON SCIENTIFIC CORP | -8,378,854 | -$379.17M | 0 | 3 | 3 | 0 | 7 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | -6,876,964 | -$83.84M | 2 | 2 | 3 | 0 | 7 |
| FATE | FATE THERAPEUTICS INC | -4,699,632 | -$42.67M | 0 | 0 | 2 | 1 | 2 |
| NUVB | NUVATION BIO INC | -4,679,294 | -$1.01M | 0 | 1 | 0 | 1 | 3 |
| EXAS | EXACT SCIENCES CORP | -4,443,318 | -$21.89M | 1 | 1 | 3 | 0 | 6 |
| FMS | FRESENIUS MEDICAL CARE-ADR | -3,793,857 | $60.67M | 0 | 2 | 1 | 1 | 3 |
| AGL | AGILON HEALTH INC | -3,628,398 | -$11.82M | 0 | 1 | 2 | 0 | 3 |
| OSCR | OSCAR HEALTH INC - CLASS A | -3,567,819 | $41.64M | 0 | 2 | 1 | 0 | 4 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | -3,017,534 | -$445.91M | 0 | 2 | 5 | 1 | 8 |
| WBA | WALGREENS BOOTS ALLIANCE INC | -2,015,275 | $9.95M | 1 | 6 | 1 | 0 | 9 |
| AMLX | AMYLYX PHARMACEUTICALS INC | -1,850,351 | -$84.33M | 0 | 0 | 1 | 1 | 1 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -1,807,071 | $1.24M | 0 | 1 | 2 | 1 | 4 |
| SNY | SANOFI-ADR | -1,693,372 | $415.68M | 1 | 4 | 3 | 0 | 8 |
| ABT | ABBOTT LABORATORIES | -1,517,849 | -$502.97M | 2 | 7 | 6 | 1 | 20 |
| AZN | ASTRAZENECA PLC-SPONS ADR | -1,476,468 | -$3.81M | 1 | 4 | 2 | 1 | 8 |
| PHG | KONINKLIJKE PHILIPS NVR- NY | -1,407,156 | $6.06M | 0 | 1 | 1 | 0 | 2 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | -1,350,531 | -$396.75K | 0 | 0 | 3 | 0 | 3 |
| GH | GUARDANT HEALTH INC | -1,271,040 | -$52.12M | 1 | 2 | 1 | 0 | 4 |
| XRAY | DENTSPLY SIRONA INC | -1,242,836 | $73.37M | 0 | 1 | 3 | 0 | 4 |
| VRTX | VERTEX PHARMACEUTICALS INC | -1,090,294 | -$61.76M | 1 | 1 | 6 | 0 | 8 |
| VTYX | VENTYX BIOSCIENCES INC | -977,200 | -$32.79M | 0 | 1 | 0 | 1 | 1 |
| VXRT | VAXART INC | -955,359 | -$3.89K | 0 | 0 | 1 | 0 | 2 |
| BDX | BECTON DICKINSON AND CO | -938,305 | -$188.75M | 0 | 6 | 8 | 0 | 15 |
| SYK | STRYKER CORP | -788,619 | $202.86M | 2 | 7 | 4 | 0 | 13 |
| NVS | NOVARTIS AG-SPONSORED ADR | -787,553 | -$11.22M | 0 | 2 | 2 | 0 | 7 |
| MNKD | MANNKIND CORP | -774,100 | -$5.45K | 0 | 0 | 1 | 0 | 1 |
| JNJ | JOHNSON & JOHNSON | -751,765 | -$274.43M | 4 | 12 | 9 | 1 | 30 |
| EW | EDWARDS LIFESCIENCES CORP | -747,799 | $41.59M | 2 | 3 | 5 | 0 | 12 |
| BFLY | BUTTERFLY NETWORK INC | -741,319 | -$6.84M | 0 | 1 | 3 | 0 | 4 |
| IDXX | IDEXX LABORATORIES INC | -710,814 | $82.85M | 0 | 3 | 5 | 1 | 8 |
| OPK | OPKO HEALTH INC | -702,371 | -$130.36K | 0 | 0 | 1 | 1 | 1 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | -697,245 | -$312.73M | 0 | 2 | 2 | 1 | 4 |
| NEOG | NEOGEN CORP | -633,760 | $415.82K | 0 | 0 | 1 | 1 | 2 |
| ALGN | ALIGN TECHNOLOGY INC | -617,506 | $321.00M | 1 | 0 | 8 | 2 | 9 |
| IONS | IONIS PHARMACEUTICALS INC | -580,825 | -$6.85M | 0 | 0 | 5 | 0 | 5 |
| EVH | EVOLENT HEALTH INC - A | -572,588 | -$6.41M | 0 | 0 | 1 | 0 | 1 |
| AKBA | AKEBIA THERAPEUTICS INC | -547,727 | -$355 | 0 | 0 | 1 | 0 | 1 |
| CTMX | CYTOMX THERAPEUTICS INC | -490,474 | -$861 | 0 | 0 | 1 | 0 | 1 |
| CORT | CORCEPT THERAPEUTICS INC | -479,274 | $465.29K | 1 | 0 | 1 | 0 | 2 |
| OMI | OWENS & MINOR INC | -461,917 | -$2.89M | 0 | 0 | 1 | 1 | 1 |
| HUM | HUMANA INC | -451,247 | -$15.62M | 3 | 3 | 3 | 0 | 10 |
| AMGN | AMGEN INC | -436,905 | -$7.87M | 2 | 7 | 3 | 1 | 14 |
| PODD | INSULET CORP | -414,428 | -$77.81M | 0 | 2 | 1 | 1 | 3 |
| SGRY | SURGERY PARTNERS INC | -407,063 | $25.27M | 0 | 0 | 2 | 0 | 2 |
| CAH | CARDINAL HEALTH INC | -398,986 | -$30.30M | 0 | 4 | 4 | 1 | 9 |
| VTRS | VIATRIS INC | -385,340 | -$3.39M | 1 | 2 | 5 | 0 | 8 |
| ADAP | ADAPTIMMUNE THERAPEUTICS-ADR | -378,273 | -$620 | 0 | 0 | 1 | 0 | 1 |
| WRBY | WARBY PARKER INC-CLASS A | -377,273 | -$43.21M | 1 | 0 | 2 | 1 | 3 |
| MREO | MEREO BIOPHARMA GROUP PL-ADR | -341,460 | -$296 | 0 | 0 | 1 | 0 | 1 |
| SIGA | SIGA TECHNOLOGIES INC | -332,971 | $57.97K | 1 | 0 | 1 | 0 | 2 |
Frequently asked questions about Most sold healthcare stocks in Q1 2023
What are the most sold Healthcare stocks in Q1 2023?
The most sold healthcare stocks in Q1 2023 are those with the largest decrease in reported share counts across institutional investors compared to Q4 2022, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q1 2023?
Among filers in this sector, net reductions were largest in companies such as BOSTON SCIENTIFIC CORP (BSX), TEVA PHARMACEUTICAL-SP ADR (TEVA), FATE THERAPEUTICS INC (FATE), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q4 2022).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.